Table: Stella Pharma - 6-MTH parent results

Stella Pharma

09/11/2022 06:20

Nov 9 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended        Year to  
                Sep 30, 2022        Sep 30, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            92 mln              69 mln            192 mln    
                 (+33.3 pct)                           (+91.8 pct)  
  Operating     loss 366 mln        loss 337 mln      loss 948 mln  
  Recurring     loss 342 mln        loss 406 mln      loss 933 mln  
  Net           loss 344 mln        loss 408 mln      loss 936 mln  
  EPS          loss 12.00 yen      loss 14.85 yen    loss 32.64 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T